W. L. Gore & Associates, a manufacturing company based in Newark, Delaware, received CE Mark approval from the European Union for its new endoprosthesis. The company’s Excluder AAA endoprosthesis features 36-millimeter aortic extender components and 35-millimeter trunk-ipsilateral legs. With the endoprosthesis, healthcare providers will be able to treat abdominal aortic aneurysms in patients with an infrarenal aortic inner-neck diameter between 19 to 32 millimeters.
The Gore Excluder endoprosthesis is a type of endovascular stent-graft. The endoprosthesis is inserted into a patient’s body through a small incision in the leg. Once in the body, the endoprosthesis is directed through the body’s circulatory system to the site of an aneurysm. When the device reaches an aneurysm, it redirects blood flow along a new path.
Approximately 135,000 Gore Excluders have been distributed to healthcare facilities around the world. With one of the lowest profiles in its class, the endoprosthesis will be a valuable tool for patients with limited stent-graft options due to sizing issues.
Ryan Takeuchi is a business leader in the aortic products division at Gore. In prepared remarks, he stated, "By expanding our sizing options to include larger anatomies, Gore now offers a complete range of sizes to treat differing anatomies with the preferred infrarenal placement.” He continued, "Gore strives to provide superior performance through design. Our extended AAA sizing portfolio and innovative delivery solution simplify the Evar procedure for physicians and patients alike."